Alchemab Therapeutics vs Celerion
Alchemab Therapeutics vs Celerion, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Alchemab Therapeutics is on 42/100 and Celerion on 59/100.
Where each one leads
Alchemab Therapeutics
Leads on none of the measures we hold for both companies.
Celerion
- our overall score: 59/100 against 42/100
- domain rating: 41/100 against 33/100
- funding raised: $45.0M against $31.5M
At a glance
| Measure | Alchemab Therapeutics | Celerion |
|---|---|---|
| What it is | Discovering and developing first-in-class antibody therapeutics by identifying protective antibodies from disease-resilient individuals. | A global leader in clinical pharmacology and bioanalytical sciences. |
| Category | Biotechnology, Pharmaceuticals, Artificial Intelligence, Drug Discovery | Biotechnology, Pharmaceuticals, Healthcare, Life Sciences |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2019 | 1975 |
| Headquarters | London, United Kingdom | Lincoln, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Alchemab Therapeutics | Celerion |
|---|---|---|
| Employees | Not published | 1,162 |
| Total funding | $31.5M | $45.0M |
| Latest round | Series A | Majority Investment |
| Valuation | Not published | $1.1B |
| LinkedIn followers | Not published | 26,451 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Alchemab Therapeutics | Celerion |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 42/100 | 59/100 |
| Traction | 37/100 | 58/100 |
| Team | Not published | 50/100 |
| Search visibility | 8/100 | 36/100 |
| Quality | 58/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (36/100) | F (38/100) |
| Domain ratingLink authority, 0-100 | 33/100 | 41/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Alchemab Therapeutics | Celerion |
|---|---|---|
| Hosting | Google Cloud | Self Managed |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery |
| Analytics | Google Analytics 4 | Google Tag Manager |
Alchemab Therapeutics vs Celerion: common questions
Which is better, Alchemab Therapeutics or Celerion?
On our 0-100 score Celerion rates higher (59/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Alchemab Therapeutics and Celerion compare on the numbers?
Celerion leads on our overall score (59/100 against 42/100), domain rating (41/100 against 33/100), funding raised ($45.0M against $31.5M).
Read the full Alchemab Therapeutics review and pricing or the Celerion review and pricing. You can also browse other Alchemab Therapeutics alternatives we track.